Top Markets
Coin of the day
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited

TaiGen Biopharmaceuticals Holdings Limited

4157
Classement en actions #18388
TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm... TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm dedicated to pioneering innovative treatments for life-altering diseases. Its robust development pipeline features several key assets. Among these is Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic currently being advanced for the treatment of various bacterial infections, including community-acquired pneumonia and diabetic foot infections. The company is also progressing Burixafor, a stem cell mobilizer with applications in stem cell transplantation and chemosensitization. Further contributing to its portfolio is TG-1000, an antiviral medication designed to combat influenza A, B, and the avian influenza H7N9 strain. Additionally, Furaprevir, a hepatitis C virus (HCV) protease inhibitor, is under development for managing chronic hepatitis C. Established in 2001, TaiGen Biopharmaceuticals maintains its headquarters in Taipei City, Taiwan.
Prix de l'action
$0.28078542
Capitalisation boursière
$199.87M
Changement (1 jour)
-0.34%
Changement (1 an)
-10.19%
Pays
TW
Échange TaiGen Biopharmaceuticals Holdings Limited (4157)

Catégorie

Historique des divisions d’actions pour TaiGen Biopharmaceuticals Holdings Limited (4157)
L’action TaiGen Biopharmaceuticals Holdings Limited (symbole : 4157) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Sep 03, 2026.
Une action 4157 achetée avant le Sep 03, 2026 équivaudrait aujourd’hui à 0 actions 4157.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH